Related Experiment Video
Updated: Jan 12, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Focal Adhesion Kinase Promotes Calcification of Vascular Smooth Muscle Cells via Regulation of Histone Deacetylase 4
Wenjie Tian1,2,3, Kuldeep Singh1, Lova P Kajuluri1
1Cardiovascular Research Center and Cardiology Division of the Heart and Vascular Institute, Boston (W.T., K.S., L.P.K., S.L., K.R., C.J.N., W.J., H.J.B., S.B., K.O., R.H.L., C.B., E.M., H.T., H.H.S., M.S.M., A.L.J., E.L.C., M.E.L., C.L.L.C., R.M.).
Background:
Vascular calcification is an active process driven by osteogenic phenotypic transition of vascular smooth muscle cells (VSMCs) and regulated by a bone-related gene regulatory network. Recent studies showed that FAK (focal adhesion kinase) regulates bone formation by affecting the cellular localization of HDAC (histone deacetylase) 4 and HDAC5. However, it is not known whether FAK exerts effects on vascular calcification in VSMCs through regulating HDACs.
Methods:
We used perturbational assays to assess the role of HDAC4, HDAC5, and FAK in VSMC calcification. Pharmacological inhibition and gene silencing of FAK were used to evaluate effects on calcification, cell migration, and the expression of procalcification factors. Leptomycin was used to inhibit the nuclear export of HDACs. In addition, ex vivo cultures of mouse and human arteries were treated with a FAK inhibitor to assess effects on arterial calcification. Single-cell transcriptomic expression of FAK was examined in healthy and diseased human coronary arteries.
Results:
HDAC4 and HDAC5 were identified as positive regulators of vascular calcification. Pharmacological inhibition or gene silencing of FAK blocked VSMC calcification, abrogated the osteogenic medium-induced elevation of procalcification factors, and reduced cell migration. FAK inhibition reduced HDAC4 and HDAC5 phosphorylation and enhanced nuclear localization of these HDAC proteins. Inhibition of HDAC4 and HDAC5 nuclear export with leptomycin showed similar effects on calcification as FAK inhibition. Treatment with the FAK inhibitor attenuated the calcification of ex vivo mouse and human arteries. FAK gene expression was dysregulated in human diseased coronary arteries compared with healthy coronary arteries, and, in single-cell analysis of human arterial tissue, FAK expression was highest in VSMCs at an intermediate state between contractile and osteogenic phenotypes.
Conclusions:
FAK promotes VSMC calcification, at least in part, via phosphorylation of HDAC4 and HDAC5. Targeted regulation of the activity of FAK, HDAC4, and HDAC5 may be an effective strategy for the treatment of vascular calcification.
Insights
Focal adhesion kinase (FAK) promotes vascular calcification by regulating histone deacetylases (HDACs) 4 and 5. Targeting FAK, HDAC4, and HDAC5 may offer new treatments for vascular calcification.
Area of Science:
- Vascular Biology
- Cell Biology
- Molecular Medicine
Background:
- Vascular calcification is an active process involving the osteogenic transition of vascular smooth muscle cells (VSMCs).
- Focal adhesion kinase (FAK) influences bone formation by regulating histone deacetylase (HDAC) 4 and 5 localization.
- The role of FAK in vascular calcification via HDAC regulation in VSMCs remains unclear.
Purpose of the Study:
- To investigate the role of FAK in VSMC calcification.
- To determine if FAK regulates vascular calcification through HDAC4 and HDAC5.
- To explore FAK as a potential therapeutic target for vascular calcification.
Main Methods:
- Utilized perturbational assays, including pharmacological inhibition and gene silencing of FAK.
- Assessed effects on VSMC calcification, migration, and procalcification factor expression.
- Examined the impact of inhibiting HDAC nuclear export and analyzed FAK expression in human coronary arteries.
Main Results:
- HDAC4 and HDAC5 are identified as positive regulators of vascular calcification.
- FAK inhibition blocked VSMC calcification, reduced procalcification factors, and decreased cell migration.
- FAK inhibition enhanced nuclear localization of HDAC4 and HDAC5, and attenuated arterial calcification ex vivo.
Conclusions:
- FAK promotes VSMC calcification, partly through HDAC4 and HDAC5 phosphorylation.
- Targeting FAK, HDAC4, and HDAC5 presents a potential therapeutic strategy for vascular calcification.
More Related Videos
11:30A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
08:28Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro
Published on: February 15, 2022
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Regulation of Angiogenesis and Blood Supply
Smooth Muscle Contraction
The onset of contraction is triggered by an increase in calcium ions within the sarcoplasm, similar to the process in striated muscle. However, smooth muscles have a relatively smaller reservoir of the sarcoplasmic...
Tension Response at Adherens Junctions
α-Catenin as a Mechanosensory Protein
The α-catenin of adherens junctions is an allosteric protein with three VH (vinculin...
cAMP-dependent Protein Kinase Pathways